International Study Reports COVID-19 Outcomes in People With Cystic Fibrosis
Today the Cystic Fibrosis Foundation announced data from a collaborative, international effort to understand the impact of COVID-19 on...
Case Report Cites IDPN as Nutritional Tool in CF Patients with Kidney Disease
Delivering nutrients through dialysis could help people with co-occurring cystic fibrosis (CF) and kidney disease meet their nutritional...
Protein Called TAS2R38 Linked to Respiratory Tract Complications in CF
Problems with a protein called TAS2R38 are linked to a greater risk of severe sinonasal disease and Pseudomonas aeruginosa lung...
Staphylococcus Aureus in CF Airways Change With Age, Antibiotic Use, Study Says
Different types of Staphylococcus aureus can be found persistently in the airways of cystic fibrosis (CF) patients, but this bacteria...
Planned CHOICES Trial in Rare CF Mutations Given Regulatory Support
Proteostasis Therapeutics reported receiving scientific advice for its CHOICES clinical trial program, which is to test its personalized...
Simulations show how to make gene therapy more effective
Visualisation of a lipoplex entrapped inside an endosome. The DNA (yellow/pink rods) can only escape upon fusion of the lipoplex (red)...
Breaking the Diagnosis of Cystic Fibrosis to Parents: A process not a one-off event
2019 Royal Society of Medicine Cystic Fibrosis Symposium Breaking the Diagnosis of Cystic Fibrosis to Parents: A process not a one-off...
Coronavirus update: More considered vulnerable - full list of who should stay at home
CORONAVIRUS can be dangerous for the most vulnerable members of society. As time goes on, more health conditions - that increase a...
Arrowhead Pharmaceuticals files for regulatory clearance to begin phase 1/2a study of ARO-ENaC for t
rrowhead Pharmaceuticals has filed an application for clearance to begin a Phase 1/2a clinical trial of ARO-ENaC, the company’s...
McGill spinoff Laurent Pharmaceuticals to begin clinical trial on COVID-19 treatment
Company to run a Phase 2 clinical study with LAU-7b, a pro-resolving drug with potential antiviral properties against coronavirus Junji...
